Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.420
+0.0205.00%
Volume:69.00K
Turnover:27.87K
Market Cap:259.56M
PE:-0.85
High:0.445
Open:0.445
Low:0.380
Close:0.400
52wk High:5.400
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:0.76
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.491
ROE:-242.61%
ROA:-20.57%
PB:-2.65
PE(LYR):-0.85
PS:- -

Loading ...

Market Sentiment Hits Bottom: A-Share Weekly Volume Drops to Annual Low, Nonferrous Metals Lead Decline, Innovative Drugs Struggle - Focus on Huabao Fund's ChiNext AI ETF

Deep News
·
Yesterday

WCLC年会启幕:掌握创新药临床数据解读的关键术语

Deep News
·
Yesterday

Innovative Drug Stocks Face Relentless Decline: What's Behind the Slide? Huabao's Hong Kong Connect Innovative Drug ETF Loses All Key Support Levels

Deep News
·
Yesterday

Innovative Drugs Face a Key Data Catalyst Window! Can't Tell OS, PFS, and ORR Apart? Here's a Quick Reference Guide! Save It for Later

Deep News
·
Sep 11

Market-Wide Pullback on Heavy Volume: Nonferrous Metals Hit Hard, Innovative Drugs Keep Sliding, Optical Modules Stand Out as AI ETF Stages a V-Shape Rebound

Deep News
·
Sep 11

Innovative Drug Stocks Remain Under Pressure Ahead of Key Medical Conference; Huabao HK Connect Innovative Drug ETF Breaks Below All Moving Averages

Deep News
·
Sep 11

Anglikang's In-Licensing Deal Collapses: Core Business Pressures Compound Innovation Pipeline Uncertainty

Deep News
·
Sep 11

Apichope's gout drug AR882 meets primary endpoint in Phase III trial with projected peak sales of 1.95 billion yuan in Greater China

Deep News
·
Sep 11

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities

Deep News
·
Sep 11

Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains

Stock News
·
Sep 10

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

Stock News
·
Sep 10

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Stock News
·
Sep 10

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Deep News
·
Sep 09

How Traditional Chinese Medicine Is Moving From Ancient Recipes to Evidence-Based Data

Deep News
·
Sep 09

Chengdu Easton Biopharmaceuticals Schedules Participation in Semi-Annual Innovation Drug Sector Earnings Call

Deep News
·
Sep 08

The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines

Deep News
·
Sep 08

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Deep News
·
Sep 07

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

Deep News
·
Sep 07

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Deep News
·
Sep 07